Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/1996
08/21/1996CN1129441A Vitamin D analogues
08/21/1996CN1129216A Hydroxamic acid derivatives with tricylic substitution
08/20/1996US5547971 Use of leflunomide for inhibiting interleukin 8
08/20/1996US5547970 Use of leflunomide for inhibiting tumor necrosis factor alpha
08/20/1996US5547959 For treatment of the autoimmune disease systemic lupus erythematosus
08/20/1996US5547932 Transfection
08/20/1996US5547667 Linker for bioactive agents
08/16/1996CA2169433A1 Adhesion receptor antagonists
08/15/1996WO1996024676A1 Bioactive fusion proteins and pre-existing tumor therapy
08/15/1996WO1996024672A1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6
08/15/1996WO1996024612A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
08/15/1996WO1996024611A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
08/15/1996WO1996024603A1 InK4c-p18 AND InK4D-p19, INHIBITORS OF CYCLIN-DEPEDENT KINASES CDK4 AND CDK6, AND USES THEREOF
08/15/1996WO1996024602A1 Epipodophyllotoxin triaryloxyacetyl derivatives, method for preparing same, and use of said derivatives as cancer drugs
08/15/1996WO1996024371A1 Multifunctional enzyme
08/15/1996WO1994020062A3 Balanoids as protein kinase c inhibitors
08/15/1996CA2212956A1 Epipodophyllotoxin triaryloxyacetyl derivatives, method for preparing same, and use of said derivatives as cancer drugs
08/15/1996CA2212573A1 Nucleotide and deduced amino acid sequences of tumor gene int6
08/15/1996CA2212533A1 Multifunctional enzyme
08/15/1996CA2212376A1 Ink4c-p18 and ink4d-p19, inhibitors of cyclin-dependent kinases cdk4 andcdk6, and uses thereof
08/15/1996CA2210955A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
08/15/1996CA2210953A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
08/14/1996EP0726274A2 G-cap stabilized oligonucleotides
08/14/1996EP0725826A1 Improvements relating to cancer therapy
08/14/1996EP0725823A1 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA)
08/14/1996EP0725819A1 A method for detection of alterations in the dna mismatch repair pathway
08/14/1996EP0725796A1 Growth differentiation factor-10
08/14/1996EP0725791A1 Recombinant p53 adenovirus methods and compositions
08/14/1996EP0725790A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
08/14/1996EP0725650A1 Inhibitors of farnesyl-protein transferase
08/14/1996EP0725646A1 Compositions for the prevention and treatment of viral-induced tumors
08/14/1996EP0725641A1 Novel enzyme inhibitors, their synthesis, and methods for use
08/14/1996EP0725637A1 Parenteral busulfan for treatment of malignant disease
08/14/1996EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
08/14/1996EP0725629A1 Liposomal defensins
08/14/1996EP0660823B1 N-cyano-n'-pyridylguanidines as serotonin antagonists
08/14/1996EP0636115B1 Novel bis-phenyl-hexenes
08/14/1996EP0595794B1 Cloned genes which encode elam-1 and fusion proteins thereof, the protein products expressed therefrom, pharmaceutical compositions and the use thereof
08/14/1996EP0471751B1 Antineoplastic solution and method for treating neoplasms
08/14/1996EP0464105B1 Melanin-concentrating hormones and dna for expressing the same
08/14/1996CN1128753A Alkyl benzoylguanidines derivatives
08/14/1996CN1128752A Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines, prepn. method and usage thereof
08/13/1996US5545723 Amino acid sequence where valine at position 101 is replaced with phenylalanine, tyrosine, tryptophan or histidine; diplayes an antiviral activity, that is atleast partially neutralized by antibodies to wild type interferon-beta
08/13/1996US5545669 Anti-inflammatory compounds
08/13/1996US5545662 Used to accelerate recovery from neutropenia accompanying radio or chemotherapy, bone marrow transplantation, or infections
08/13/1996US5545637 Process for preparing pharmaceutical compositions containing crystalline anhydrous mycophenolate mofetil salts
08/13/1996US5545532 Human carcinoma antigen (HCA), HCA antibodies, HCA immunoassays and methods of imaging
08/13/1996US5545405 Administering recombinant antibody glycosylated by chinese hamster ovary cell
08/13/1996US5545404 Method for treating a mammal suffering from a T-cell medicated disorder with a CHO-Glycosylated antibody
08/13/1996US5545403 Method for treating a mammal by administering a CHO-glycosylated antibody
08/08/1996WO1996024061A1 Methods and apparatus for synthesizing labeled combinatorial chemical libraries
08/08/1996WO1996023896A1 Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus
08/08/1996WO1996023893A1 Immunosuppressive and tumour-suppressive bone marrow factor
08/08/1996WO1996023883A2 Modified ligands for receptor tyrosine kinases
08/08/1996WO1996023791A1 Bridged indoles as matrix metalloprotease inhibitors
08/08/1996WO1996023787A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/08/1996WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof
08/08/1996WO1996023506A1 Use of 5'substituted nucleosides to provide resistance in cytostatic treatment and medicaments containing said nucleosides
08/08/1996WO1996023505A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
08/08/1996WO1996023498A1 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
08/08/1996WO1996023497A1 Cyclopropylpyrroloindole-oligopeptide anticancer agents
08/08/1996WO1996023489A2 Use of carotinoids for preparing medicaments for treating dermatoses
08/08/1996WO1996015816A3 Stable n-terminally linked dtpa:protein compositions and methods
08/08/1996CA2212236A1 Bridged indoles as matrix metalloprotease inhibitors
08/08/1996CA2211783A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
08/08/1996CA2211099A1 Modified ligands for receptor tyrosine kinases
08/08/1996CA2210957A1 The use of carotenoids for producing drugs for the treatment of dermatoses
08/08/1996CA2210093A1 Cyclopropylpyrroloindole-oligopeptide anticancer agents
08/08/1996CA2186943A1 Methods and apparatus for synthesizing labeled combinatorial chemical libraries
08/07/1996EP0725077A1 Novel glycoproteins, process for preparation thereof, and pharmaceutical composition
08/07/1996EP0725075A1 Peptide derivatives comprising a phosphinic acid moiety as inhibitors of zinc depending endopeptidase 24-25
08/07/1996EP0725062A1 4-mercapto-benzoylguanidine derivatives
08/07/1996EP0724884A1 Side effect inhibitor for cancer therapy
08/07/1996EP0724647A1 Nucleic acid ligands and improved methods for producing the same
08/07/1996EP0724632A1 Stem cell proliferation factor
08/07/1996EP0724594A1 Regulation of transcription factor, nf-il6/lap
08/07/1996EP0724581A1 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
08/07/1996EP0724570A1 Amidino derivatives useful as nitric oxide synthase inhibitors
08/07/1996EP0724457A1 Radiation sensitization using texaphyrins
08/07/1996EP0724440A1 Di- and tetra-hydrobenzo f]quinolin-3-ones
08/07/1996EP0507825B1 Antitumoral composition based on polypeptides having human interleukin 2 activity
08/07/1996CN1128263A Pyrrolopyrimidine derivatives having pharmacological activity
08/07/1996CN1128262A Substituted biphenyl isoxazole sulfonamides
08/07/1996CA2168827A1 Glycoproteins, process for preparation thereof, and pharmaceutical composition
08/06/1996US5543520 Pyrimidine derivatives
08/06/1996US5543422 Heterocyclic amines
08/06/1996US5543418 Innovative technique for immunosuppresion involving administration of rapamycin loaded formed blood elements
08/06/1996US5543410 Pharmacological use of phthaloylhydrazide derivatives; combination and application thereof
08/06/1996US5543408 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
08/06/1996US5543402 Antitumor agents
08/06/1996US5543140 Method and use of IL-1α
08/06/1996CA1338508C Method and compositions for treatment of parkinsonism syndrome in mammals
08/01/1996WO1996023067A1 Human interleukin-1 receptor accessory protein
08/01/1996WO1996023065A2 Inhibition of neovascularization using vegf-specific oligonucleotides
08/01/1996WO1996023001A1 New pharmaceuticals for modulating hormone responsiveness
08/01/1996WO1996022985A1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-[1]benzopyran for treating proliferative disorders
08/01/1996WO1996022979A1 Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
08/01/1996WO1996022976A1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
08/01/1996WO1996022790A1 Composition to ameliorate osteolysis and metastasis
08/01/1996WO1996022788A1 LYMPHOTOXIN-α/β COMPLEXES AND ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS
1 ... 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 ... 2211